# Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

> **NCT00014222** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 2104 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** epoetin alfa
- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00014222
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12-04
- **Primary completion:** 2014-02-10
- **Final completion:** 2014-03-17
- **Target enrollment:** 2104 (ACTUAL)
- **Last updated:** 2020-10-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014222, "Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00014222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*